Skip to main content
Premium Trial:

Request an Annual Quote

DNAmito, Varian Medical Systems Ink Software Development, OEM Pact

NEW YORK (GenomeWeb) – DNAmito and Varian Medical Systems have inked a development and OEM agreement to integrate DNAmito's Prodecis into Varian's 360 Oncology care management software.

Prodecis is a clinical-grade multifactor decision support system integrating all currently available patient data to enable personalized cancer treatment. It will enable 360 Oncology to deliver genomics-based evidence to optimize physicians' treatment decisions regarding radiation treatment for cancer, the companies said.

Varian's 360 Oncology uses predictive models based on toxicity, tumor control, quality of life, and cost effectiveness to enable clinicians to make more informed recommendations on optimal individualized treatments for each patient.

"We are excited to be selected by one of the world leaders in radiation oncology for our multifactorial decision support system for cancer treatment," Philippe Lambin, co-inventor and chief scientific advisor for Palo Alto, California-based DNAmito, said in a statement. "We have shown that [Prodecis] is an essential tool for precision medicine … [and] when combined with 360 Oncology can integrate various types of medical data available as well as proprietary gene signatures to support the choice of the best treatment."

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.